Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Digna Biotech S.L.
DescriptionInterferon (IFN) alpha-5
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C virus (HCV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today